Figure 1
Course of immunologic parameters. Cryoglobulinemia (A), C4 serum level (B), and VH1-69+ B-cell clones (C) in HCV-MC patients according to the type of treatment. RTX indicates rituximab; RBV, ribavirin; and EOF, end of follow-up.
Course of immunologic parameters. Cryoglobulinemia (A), C4 serum level (B), and VH1-69+ B-cell clones (C) in HCV-MC patients according to the type of treatment. RTX indicates rituximab; RBV, ribavirin; and EOF, end of follow-up.
